{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:25:41Z","timestamp":1783081541891,"version":"3.54.6"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["912264"],"award-info":[{"award-number":["912264"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","award":["SKGJ-MED-02"],"award-info":[{"award-number":["SKGJ-MED-02"]}],"id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010688","name":"Horizon 2020 European Innovation Council Fast Track to Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010970","name":"Chiropractic and Osteopathic College of Australasia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neuint.2023.105629","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:27:35Z","timestamp":1697776055000},"page":"105629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12\u00a0cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-2779","authenticated-orcid":false,"given":"Peter D.","family":"Szigetvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-7959","authenticated-orcid":false,"given":"Sudarshan","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4605-0762","authenticated-orcid":false,"given":"Even","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6086-755X","authenticated-orcid":false,"given":"Rune","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2808","authenticated-orcid":false,"given":"Jan","family":"Haavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13010062","article-title":"The extracellular bone marrow microenvironment\u2014a proteomic comparison of constitutive protein release by in vitro cultured osteoblasts and mesenchymal stem cells","volume":"13","author":"Aaseb\u00f8","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.neuint.2023.105629_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1026239921561","article-title":"Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression","volume":"31","author":"Antshel","year":"2003","journal-title":"J. Abnorm. Child Psychol."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:BOLI.0000028725.37345.62","article-title":"Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria","volume":"27","author":"Arnold","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj2060165","article-title":"Enhancement of rat brain catecholamine synthesis by administration of small doses of tyrosine and evidence for substrate inhibition of tyrosine hydroxylase activity by large doses of the amino acid","volume":"206","author":"Badawy","year":"1982","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.b.32764","article-title":"Tyrosinemia Type 1 and symptoms of ADHD: biochemical mechanisms and implications for treatment and prognosis","volume":"183","author":"Barone","year":"2020","journal-title":"Am. J. Med. Genet., Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.neuint.2023.105629_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1213590","article-title":"Case report: ADHD and prognosis in tyrosinemia type 1","volume":"14","author":"Barone","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpeds.2013.10.001","article-title":"Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone","volume":"164","author":"Bendadi","year":"2014","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0026-0495(96)90210-3","article-title":"Intravenous \u03b3-glutamyl-tyrosine elevates brain tyrosine but not catecholamine concentrations in normal rats","volume":"45","author":"Berger","year":"1996","journal-title":"Metabolism"},{"issue":"21","key":"10.1016\/j.neuint.2023.105629_bib9","article-title":"Homeostatic mechanisms in dopamine synthesis and release: a mathematical model","volume":"6","author":"Best","year":"2009","journal-title":"Theor. Biol. Med. Model."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2023.105629_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1252024","article-title":"Models of dopaminergic and serotonergic signaling","volume":"43","author":"Best","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuint.2023.105629_bib11","series-title":"Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases","author":"Blau","year":"1996"},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365513.2012.676210","article-title":"Hereditary tyrosinaemia type I in Norway: incidence and three novel small deletions in the fumarylacetoacetase gene","volume":"72","author":"Bliksrud","year":"2012","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2006.07.074","article-title":"Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine","volume":"1115","author":"Bongiovanni","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2023.105629_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6031478","article-title":"Noradrenergic modulation of cognition in Health and disease","volume":"2017","author":"Borodovitsyna","year":"2017","journal-title":"Neural Plast."},{"issue":"7","key":"10.1016\/j.neuint.2023.105629_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.neuint.2012.07.012","article-title":"Increased tyrosine availability increases brain regional DOPA levels in vivo","volume":"61","author":"Brodnik","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2023.105629_bib16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.neubiorev.2021.11.012","article-title":"ADHD symptoms in neurometabolic diseases: underlying mechanisms and clinical implications","volume":"132","author":"Cannon Homaei","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib17","article-title":"Assessing the effect of nitisinone induced hypertyrosinaemia on monoamine neurotransmitters in brain tissue from a murine model of alkaptonuria using mass spectrometry imaging","volume":"15","author":"Davison","year":"2019","journal-title":"Metabolomics"},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib18","first-page":"302","article-title":"Genetic epidemiology of hereditary tyrosinemia in quebec and in saguenay-lac-st-jean","volume":"47","author":"De Braekeleer","year":"1990","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11064-013-1207-9","article-title":"l-Tyrosine induces DNA damage in brain and blood of rats","volume":"39","author":"De Pr\u00e1","year":"2014","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11064-022-03735-5","article-title":"1\u03b1,25-Dihydroxyvitamin D3 (VD3) shows a neuroprotective action against rotenone toxicity on PC12 cells: an in vitro model of Parkinson's disease","volume":"48","author":"de Siqueira","year":"2023","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.neuint.2023.105629_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1023\/A:1021044708116","article-title":"The effect of phenylalanine on DOPA synthesis in PC12 cells","volume":"23","author":"DePietro","year":"1998","journal-title":"Neurochem. Res."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2023.105629_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(99)01400-6","article-title":"The relative roles of phenylalanine and tyrosine as substrates for DOPA synthesis in PC12 cells","volume":"831","author":"DePietro","year":"1999","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1046\/j.1432-1033.2002.02808.x","article-title":"Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form","volume":"269","author":"D\u00f8skeland","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"9","key":"10.1016\/j.neuint.2023.105629_bib24","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0093-691X(01)00532-5","article-title":"Amino acid concentrations in fluids from the bovine oviduct and uterus and in ksom-based culture media","volume":"55","author":"Elhassan","year":"2001","journal-title":"Theriogenology"},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1079\/PNS19940047","article-title":"Dietary effects on tyrosine availability and catecholamine synthesis in the central nervous system: possible relevance to the control of protein intake","volume":"53","author":"Fernstrom","year":"1994","journal-title":"Proc. Nutr. Soc."},{"issue":"6","key":"10.1016\/j.neuint.2023.105629_bib26","doi-asserted-by":"crossref","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J. Nutr."},{"issue":"15","key":"10.1016\/j.neuint.2023.105629_bib27","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/bi00229a010","article-title":"Steady-state kinetic mechanism of rat tyrosine hydroxylase","volume":"30","author":"Fitzpatrick","year":"1991","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bj2680525","article-title":"Phenylalanine as substrate for tyrosine hydroxylase in bovine adrenal chromaffin cells","volume":"268","author":"Fukami","year":"1990","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25563-x","article-title":"Quantitative modelling of amino acid transport and homeostasis in mammalian cells","volume":"12","author":"Gauthier-Coles","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.14872","article-title":"Serine 19 phosphorylation and 14\u20103\u20103 binding regulate phosphorylation and dephosphorylation of tyrosine hydroxylase on serine 31 and serine 40","volume":"152","author":"Ghorbani","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2023.105629_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0076-6879(87)47111-5","article-title":"PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation","volume":"147","author":"Greene","year":"1987","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuint.2023.105629_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.925442","article-title":"Genome guided personalized drug therapy in attention deficit hyperactivity disorder","volume":"13","author":"Haavik","year":"2022","journal-title":"Front. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuint.2023.105629_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/mgme.2000.2985","article-title":"\u201cHypotyrosinemia\u201d in phenylketonuria","volume":"69","author":"Hanley","year":"2000","journal-title":"Mol. Genet. Metabol."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10545-013-9675-2","article-title":"Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)","volume":"37","author":"Harding","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"24","key":"10.1016\/j.neuint.2023.105629_bib35","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"Copasi - a COmplex PAthway SImulator","volume":"22","author":"Hoops","year":"2006","journal-title":"Bioinformatics"},{"issue":"Suppl. l","key":"10.1016\/j.neuint.2023.105629_bib36","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ymgme.2013.10.001","article-title":"Executive functioning in context: relevance for treatment and monitoring of phenylketonuria","volume":"110","author":"Huijbregts","year":"2013","journal-title":"Mol. Genet. Metabol."},{"issue":"6","key":"10.1016\/j.neuint.2023.105629_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ajmg.b.32339","article-title":"Epistatic and gene wide effects in YWHA and aromatic amino hydroxylase genes across ADHD and other common neuropsychiatric disorders: association with YWHAE","volume":"168","author":"Jacobsen","year":"2015","journal-title":"Am. J. Med. Genet., Part B: Neuropsychiatric Genetics"},{"issue":"9","key":"10.1016\/j.neuint.2023.105629_bib38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/44.9.8773564","article-title":"Expression of dopamine transporter at the tips of growing neurites of PC12 cells","volume":"44","author":"Kadota","year":"1996","journal-title":"J. Histochem. Cytochem. : Off. J. Histochem. Soc."},{"key":"10.1016\/j.neuint.2023.105629_bib39","series-title":"Advances in Enzymology and Related Areas of Molecular Biology","first-page":"103","article-title":"Tyrosine hydroxylase","author":"Kaufman","year":"1995"},{"issue":"11","key":"10.1016\/j.neuint.2023.105629_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113779","article-title":"Degradation of tyrosine hydroxylase by the ubiquitin-proteasome system in the pathogenesis of Parkinson's disease and dopa-responsive dystonia","volume":"21","author":"Kawahata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2023.105629_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1039\/C8FD00020D","article-title":"Electrochemical quantification of transmitter concentration in single nanoscale vesicles isolated from PC12 cells","volume":"210","author":"Li","year":"2018","journal-title":"Faraday Discuss"},{"issue":"8823","key":"10.1016\/j.neuint.2023.105629_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet (London, England)"},{"issue":"Pt 3","key":"10.1016\/j.neuint.2023.105629_bib43","article-title":"Hexachloronaphthalene (HxCN) impairs the dopamine pathway in an in vitro model of PC12 cells","volume":"287","author":"Lisek","year":"2022","journal-title":"Chemosphere"},{"issue":"3","key":"10.1016\/j.neuint.2023.105629_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00441411","article-title":"Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine","volume":"148","author":"Lykkelund","year":"1988","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.neuint.2023.105629_bib45","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s11064-013-1180-3","article-title":"Effect of acute administration of l-tyrosine on oxidative stress parameters in brain of young rats","volume":"38","author":"Mac\u00eado","year":"2013","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuint.2023.105629_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","article-title":"Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice","volume":"9","author":"Mayorandan","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.neuint.2023.105629_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.mp.4002152","article-title":"A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit\/hyperactivity disorder","volume":"13","author":"McKinney","year":"2008","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuint.2023.105629_bib50","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine Hydroxylase: the initial step in norepinephrine biosynthesis","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00702-016-1653-z","article-title":"Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs","volume":"125","author":"Nakashima","year":"2018","journal-title":"J. Neural. Transm."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1022482604276","article-title":"Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids","volume":"23","author":"Pardridge","year":"1998","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.neuint.2023.105629_bib53","first-page":"96","article-title":"Behavioral and intellectual functioning in patients with tyrosinemia type I","volume":"18","author":"Pohorecka","year":"2012","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib54","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1046\/j.1471-4159.1998.71052132.x","article-title":"Mutational analysis of substrate inhibition in tyrosine hydroxylase","volume":"71","author":"Quinsey","year":"1998","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuint.2023.105629_bib55","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/bies.200900167","article-title":"The biological significance of substrate inhibition: a mechanism with diverse functions","volume":"32","author":"Reed","year":"2010","journal-title":"Bioessays"},{"issue":"24","key":"10.1016\/j.neuint.2023.105629_bib56","doi-asserted-by":"crossref","first-page":"16207","DOI":"10.1016\/S0021-9258(18)98536-4","article-title":"The hydroxylation of phenylalanine and tyrosine by tyrosine hydroxylase from cultured pheochromocytoma cells","volume":"266","author":"Ribeiro","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/jphysiol.1979.sp012636","article-title":"Catecholamine secretion in a rat pheochromocytoma cell line: two pathways for calcium entry","volume":"286","author":"Ritchie","year":"1979","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.neuint.2023.105629_bib58","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/iub.1144","article-title":"Mechanisms of tryptophan and tyrosine hydroxylase","volume":"65","author":"Roberts","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neuint.2023.105629_bib59","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1091\/mbc.e05-08-0792","article-title":"Rab1 defines a novel pathway connecting the pre-golgi intermediate compartment with the cell periphery","volume":"17","author":"Sannerud","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.neuint.2023.105629_bib60","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(21)00092-9","article-title":"Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study","volume":"9","author":"Spiekerkoetter","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neuint.2023.105629_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainresbull.2013.10.003","article-title":"A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?","volume":"99","author":"Stevenson","year":"2013","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jnc.14624","article-title":"The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity","volume":"148","author":"Szigetvari","year":"2019","journal-title":"J. Neurochem."},{"issue":"7729","key":"10.1016\/j.neuint.2023.105629_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41586-018-0654-5","article-title":"Shared and distinct transcriptomic cell types across neocortical areas","volume":"563","author":"Tasic","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000497806","article-title":"L-Tyr-induced phosphorylation of tyrosine hydroxylase at Ser 40 : an alternative route for dopamine synthesis and modulation of Na +\/K + -ATPase in kidney cells","volume":"44","author":"Taveira-Da-Silva","year":"2019","journal-title":"Kidney Blood Press. Res."},{"issue":"12","key":"10.1016\/j.neuint.2023.105629_bib65","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00702-014-1238-7","article-title":"Complex molecular regulation of tyrosine hydroxylase","volume":"121","author":"Tekin","year":"2014","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2010.11.003","article-title":"Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I","volume":"102","author":"Thimm","year":"2011","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-011-9394-5","article-title":"Neurocognitive outcome in patients with hypertyrosinemia type i after long-term treatment with NTBC","volume":"35","author":"Thimm","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-016-0472-5","article-title":"Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls","volume":"11","author":"Van Ginkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neuint.2023.105629_bib69","series-title":"Hereditary Tyrosinemia","first-page":"111","article-title":"Neurological and neuropsychological problems in tyrosinemia type I patients","author":"van Ginkel","year":"2017"},{"issue":"2022","key":"10.1016\/j.neuint.2023.105629_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2022.07.001","article-title":"Biochemical and behavioural profile of NTBC treated Tyrosinemie type 1 mice","volume":"137","author":"van Ginkel","year":"2022","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13023-019-1259-2","article-title":"Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients","volume":"14","author":"van Vliet","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"162","key":"10.1016\/j.neuint.2023.105629_bib72","first-page":"1","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"Van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.neuint.2023.105629_bib73","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2009.1308","article-title":"Evaluating dopamine reward pathway in ADHD: clinical implications","volume":"302","author":"Volkow","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neuint.2023.105629_bib74","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.psyneuen.2010.12.012","article-title":"Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective","volume":"36","author":"Waider","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuint.2023.105629_bib75","first-page":"97","article-title":"Three cases of hereditary tyrosinaemia type 1: neuropsychiatric outcomes and brain imaging following treatment with NTBC","volume":"40","author":"Walker","year":"2018","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/molpharm.120.000184","article-title":"Cysteine modification by ebselen reduces the stability and cellular levels of 14-3-3 Proteins","volume":"100","author":"Wal\u00f8en","year":"2021","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2023.105629_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1990.tb01884.x","article-title":"Use of microdialysis for monitoring tyrosine hydroxylase activity in the brain of conscious rats","volume":"54","author":"Westerink","year":"1990","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuint.2023.105629_bib78","first-page":"27","article-title":"The amino acid content of the ultrafiltrate from horse serum","volume":"15","author":"Westfall","year":"1954","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"4146","key":"10.1016\/j.neuint.2023.105629_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.185.4146.183","article-title":"Brain catechol synthesis: control by brain tyrosine concentration","volume":"185","author":"Wurtman","year":"1974","journal-title":"Science"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018623001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018623001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:04:20Z","timestamp":1759313060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018623001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":79,"alternative-id":["S0197018623001572"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2023.105629","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12\u00a0cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2023.105629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105629"}}